Cargando…
Dexamethasone implant (0.7 mg) in Indian patients with macular edema: Real-life scenario
CONTEXT: Role of Ozurdex in macular edema due to various posterior segment pathologies. AIM: The aim of this study is to report outcome of Ozurdex implant in macular edema (ME) secondary to various posterior segment pathologies. SETTINGS AND DESIGN: This was a single-center, retrospective, intervent...
Autores principales: | Nagpal, Manish, Mehrotra, Navneet, Juneja, Rakesh, Jain, Hardik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169328/ https://www.ncbi.nlm.nih.gov/pubmed/30294527 http://dx.doi.org/10.4103/tjo.tjo_62_17 |
Ejemplares similares
-
Cystoid Macular Edema after Complicated Cataract Surgery Resolved by an Intravitreal Dexamethasone 0.7-mg Implant
por: Meyer, Linda M., et al.
Publicado: (2011) -
Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants
por: Brynskov, Troels, et al.
Publicado: (2013) -
Short-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edema
por: Al Zamil, Waseem M.
Publicado: (2015) -
Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
por: Lam, Wai-Ching, et al.
Publicado: (2015) -
Fast Resolution of Recurrent Pronounced Macular Edema following Intravitreal Injection of Dexamethasone 0.7 mg
por: Meyer, Linda M., et al.
Publicado: (2011)